Giuseppe Tambussi

7.7k total citations
149 papers, 5.3k citations indexed

About

Giuseppe Tambussi is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Giuseppe Tambussi has authored 149 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 109 papers in Virology, 80 papers in Infectious Diseases and 60 papers in Immunology. Recurrent topics in Giuseppe Tambussi's work include HIV Research and Treatment (109 papers), HIV/AIDS drug development and treatment (57 papers) and HIV/AIDS Research and Interventions (53 papers). Giuseppe Tambussi is often cited by papers focused on HIV Research and Treatment (109 papers), HIV/AIDS drug development and treatment (57 papers) and HIV/AIDS Research and Interventions (53 papers). Giuseppe Tambussi collaborates with scholars based in Italy, United States and United Kingdom. Giuseppe Tambussi's co-authors include Adriano Lazzarin, Ermanno Ciccone, Cristina Bottino, Alessandro Moretta, Lorenzo Moretta, Giuseppe Pantaleo, O Viale, Silvano Ferrini, Annalisa Merli and G. Tripodi and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Giuseppe Tambussi

146 papers receiving 5.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Giuseppe Tambussi Italy	42	2.7k	2.7k	1.9k	1.0k	688	149	5.3k
Lance E. Hultin United States	33	3.5k 1.3×	2.9k 1.1×	1.7k 0.9×	1.3k 1.2×	833 1.2×	47	5.3k
Anita De Rossi Italy	45	2.8k 1.0×	1.5k 0.6×	2.5k 1.3×	1.5k 1.5×	646 0.9×	242	6.4k
John Zaunders Australia	44	3.0k 1.1×	4.1k 1.5×	1.7k 0.9×	1.3k 1.3×	328 0.5×	138	6.8k
Dörte Hamann Netherlands	38	2.2k 0.8×	3.8k 1.4×	1.2k 0.6×	1.5k 1.4×	359 0.5×	79	6.9k
A S Fauci United States	34	3.4k 1.2×	2.3k 0.9×	2.1k 1.1×	1.2k 1.2×	320 0.5×	52	5.1k
Laurence Weiss France	42	2.5k 0.9×	2.7k 1.0×	1.9k 1.0×	1.3k 1.3×	643 0.9×	140	5.6k
Hernán Valdez United States	43	2.3k 0.8×	2.5k 0.9×	1.7k 0.9×	1.4k 1.3×	498 0.7×	154	7.1k
Sigrid A. Otto Netherlands	29	2.6k 0.9×	3.1k 1.2×	1.1k 0.6×	1.1k 1.1×	434 0.6×	55	4.8k
Tarsem Moudgil United States	19	2.3k 0.8×	1.6k 0.6×	1.6k 0.8×	740 0.7×	188 0.3×	36	3.8k
Jeffrey Laurence United States	40	995 0.4×	1.6k 0.6×	2.4k 1.3×	935 0.9×	475 0.7×	130	5.4k

Countries citing papers authored by Giuseppe Tambussi

Since Specialization

Citations

This map shows the geographic impact of Giuseppe Tambussi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giuseppe Tambussi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giuseppe Tambussi more than expected).

Fields of papers citing papers by Giuseppe Tambussi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giuseppe Tambussi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giuseppe Tambussi. The network helps show where Giuseppe Tambussi may publish in the future.

Co-authorship network of co-authors of Giuseppe Tambussi

This figure shows the co-authorship network connecting the top 25 collaborators of Giuseppe Tambussi. A scholar is included among the top collaborators of Giuseppe Tambussi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giuseppe Tambussi. Giuseppe Tambussi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Alagaratnam, Jasmini, Wolfgang Stöhr, Elizabeth Hamlyn, et al.. (2024). Impact of interrupting antiretroviral therapy started during primary HIV-1 infection on plasma neurofilament light chain protein, a marker of neuronal injury: The SPARTAC trial. Journal of Virus Eradication. 10(2). 100381–100381. 1 indexed citations

Baker, Jason V., Shweta Sharma, Amit C. Achhra, et al.. (2017). Changes in Cardiovascular Disease Risk Factors With Immediate Versus Deferred Antiretroviral Therapy Initiation Among HIV‐Positive Participants in the START (Strategic Timing of Antiretroviral Treatment) Trial. Journal of the American Heart Association. 6(5). 48 indexed citations

Ripa, Marco, Stefania Chiappetta, & Giuseppe Tambussi. (2017). Immunosenescence and hurdles in the clinical management of older HIV-patients. Virulence. 8(5). 508–528. 12 indexed citations

Katlama, Christine, Sidonie Lambert-Niclot, Lambert Assoumou, et al.. (2015). Treatment intensification followed by interleukin-7 reactivates HIV without reducing total HIV DNA. AIDS. 30(2). 221–230. 54 indexed citations

Gianotti, Nicola, Andrea Poli, Silvia Nozza, et al.. (2015). Efficacy and safety in clinical practice of a rilpivirine, tenofovir and emtricitabine single‐tablet regimen in virologically suppressed HIV‐positive patients on stable antiretroviral therapy. Journal of the International AIDS Society. 18(1). 20037–20037. 9 indexed citations

Williams, James P., Jacob Hurst, Wolfgang Stöhr, et al.. (2014). HIV-1 DNA predicts disease progression and post-treatment virological control. eLife. 3. e03821–e03821. 201 indexed citations

Nozza, Silvia, Laura Galli, Sonja Chiappetta, et al.. (2012). Maraviroc 150 mg QD plus lopinavir/ritonavir, a NRTI‐sparing regimen for HIV‐infected naïve patients: 48‐weeks final results. Journal of the International AIDS Society. 15(S4). 1–2. 3 indexed citations

Riva, Chiara, Alessia Lai, Ilaria Caramma, et al.. (2010). Transmitted HIV Type 1 Drug Resistance and Non-B Subtypes Prevalence among Seroconverters and Newly Diagnosed Patients from 1992 to 2005 in Italy. AIDS Research and Human Retroviruses. 26(1). 41–49. 15 indexed citations

Chiara, Giulia Della, Claudio Fortis, Giuseppe Tambussi, & Guido Poli. (2010). The rise and fall of intermittent interleukin-2 therapy in HIV infection.. PubMed. 21(3). 197–201. 5 indexed citations

10.

Nozza, Silvia, Laura Galli, Alessandro Soria, et al.. (2010). Raltegravir, maraviroc, etravirine: an effective protease inhibitor and nucleoside reverse transcriptase inhibitor-sparing regimen for salvage therapy in HIV-infected patients with triple-class experience. AIDS. 24(6). 924–928. 37 indexed citations

11.

Fortis, Claudio, Laura Soldini, Silvia Ghezzi, et al.. (2002). Tumor Necrosis Factor α , Interleukin 2, and Soluble Interleukin 2 Receptor Levels in Human Immunodeficiency Virus Type 1-Infected Individuals Receiving Intermittent Cycles of Interleukin 2. AIDS Research and Human Retroviruses. 18(7). 491–499. 7 indexed citations

12.

Poggi, Alessandro, Roberta Carosio, Grazia Maria Spaggiari, et al.. (2002). NK Cell Activation by Dendritic Cells Is Dependent on LFA-1-Mediated Induction of Calcium-Calmodulin Kinase II: Inhibition by HIV-1 Tat C-Terminal Domain. The Journal of Immunology. 168(1). 95–101. 64 indexed citations

13.

Galli, Andrea, et al.. (2002). Selective enrichment of CD30-expressing cells within the blast region of lymphocytes from patients with primary HIV infection (PHI).. PubMed. 16(1). 33–6. 3 indexed citations

14.

Lopalco, Lucia, Claudia Barassi, Claudia Pastori, et al.. (2000). CCR5-Reactive Antibodies in Seronegative Partners of HIV-Seropositive Individuals Down-Modulate Surface CCR5 In Vivo and Neutralize the Infectivity of R5 Strains of HIV-1 In Vitro. The Journal of Immunology. 164(6). 3426–3433. 97 indexed citations

15.

Ghezzi, Silvia, Elisa Vicenzi, Laura Soldini, et al.. (1998). Experiences in immune reconstitution. The rationale for interleukin-2 administration to HIV-infected individuals.. PubMed. 11(1-2). 74–8. 7 indexed citations

16.

Tambussi, Giuseppe, et al.. (1994). Transitory Expansion of a CD3 ⁺ TcR γ/δ ⁺ CD16 ⁺ Lymphocytic Population in Two Patients with Advanced Human Immunodeficiency Virus Infection and High Levels of Natural Killer Activity. AIDS Research and Human Retroviruses. 10(6). 711–715. 4 indexed citations

17.

Ciccone, Emily J., Daniela Pende, O Viale, et al.. (1990). Specific recognition of human CD3-CD16+ natural killer cells requires the expression of an autosomic recessive gene on target cells.. The Journal of Experimental Medicine. 172(1). 47–52. 77 indexed citations

18.

Moretta, Alessandro, Cristina Bottino, Ermanno Ciccone, et al.. (1988). Human peripheral blood lymphocytes bearing T cell receptor gamma/delta. Expression of CD8 differentiation antigen correlates with the expression of the 55-kD, C gamma 2-encoded gamma chain.. The Journal of Experimental Medicine. 168(6). 2349–2354. 31 indexed citations

19.

Ciccone, Ermanno, O Viale, Cristina Bottino, et al.. (1988). Antigen recognition by human T cell receptor gamma-positive lymphocytes. Specific lysis of allogeneic cells after activation in mixed lymphocyte culture.. The Journal of Experimental Medicine. 167(4). 1517–1522. 84 indexed citations

20.

Pantaleo, Giuseppe, Maria Raffaella Zocchi, Silvano Ferrini, et al.. (1988). Human cytolytic cell clones lacking surface expression of T cell receptor alpha/beta or gamma/delta. Evidence that surface structures other than CD3 or CD2 molecules are required for signal transduction.. The Journal of Experimental Medicine. 168(1). 13–24. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact